Correlation Between Krebs Biochemicals and Bosch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Bosch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Bosch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and Bosch Limited, you can compare the effects of market volatilities on Krebs Biochemicals and Bosch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Bosch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Bosch.

Diversification Opportunities for Krebs Biochemicals and Bosch

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Krebs and Bosch is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Bosch Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bosch Limited and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Bosch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bosch Limited has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Bosch go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Bosch

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to under-perform the Bosch. In addition to that, Krebs Biochemicals is 2.74 times more volatile than Bosch Limited. It trades about -0.27 of its total potential returns per unit of risk. Bosch Limited is currently generating about -0.68 per unit of volatility. If you would invest  3,649,900  in Bosch Limited on October 16, 2024 and sell it today you would lose (551,925) from holding Bosch Limited or give up 15.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  Bosch Limited

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Bosch Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bosch Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Krebs Biochemicals and Bosch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and Bosch

The main advantage of trading using opposite Krebs Biochemicals and Bosch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Bosch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bosch will offset losses from the drop in Bosch's long position.
The idea behind Krebs Biochemicals and and Bosch Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets